Injective INJ
Rank #97Injective Overview
As of September 7, 2026, Injective (INJ) is trading at $5.68, up 10.36% over the past 24 hours. It ranks #97 by market capitalisation, currently valued at $555.57M, on $78.40M of trading volume in the last 24 hours.
Injective Price Chart Binance
Performance
Market Metrics
Technical Analysis live indicator readings
Moving Averages
Oscillators
Support & Resistance daily pivot levels
All indicators are computed from Binance daily OHLC. This is a summary of current technical readings (overbought/oversold & trend model) — not a price forecast, and not investment advice.
Correlations 90-day, vs majors
Pearson correlation of daily returns over the last 90 days (Binance). +1 moves together, 0 unrelated, −1 moves opposite.
Derivatives Hyperliquid perps
Markets Binance spot
| Pair | Price | 24h Volume |
|---|---|---|
| INJ/USDT | $5.66 | ≈ $10.40M |
| INJ/TRY | 273.7 TRY | ≈ $1.83M |
| INJ/USDC | $5.67 | ≈ $1.26M |
| INJ/TUSD | $26.23 | ≈ $550.2K |
| INJ/BNB | 0.004703 BNB | ≈ $488.5K |
| INJ/ETH | 0.001559 ETH | ≈ $476.1K |
| INJ/BTC | 0.00007122 BTC | ≈ $405.8K |
Live spot pairs on Binance, ranked by USD-equivalent 24-hour volume. For information only.
Price History last 30 days
| Date | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| Loading… | |||||
INJ Calculators
Injective Price in Other Currencies
Converted from USD at European Central Bank reference rates (frankfurter.app), updated daily.
Compare with Top Coins
| Coin | Price | 24h | Market Cap |
|---|---|---|---|
| BitcoinBTC | $79,441.99 | −0.65% | $1.60T |
| EthereumETH | $2,492.18 | −0.41% | $304.11B |
| TetherUSDT | $1.00 | +0.00% | $183.44B |
| BNBBNB | $744.73 | −1.84% | $99.17B |
| XRPXRP | $1.40 | −1.30% | $87.98B |
| USDCUSDC | $1.00 | +0.00% | $74.45B |
| SolanaSOL | $105.14 | −1.33% | $61.63B |
| InjectiveINJ | $5.68 | +10.36% | $555.57M |
Market Sentiment
Popular Injective searches
Market data is aggregated from public sources (Binance, CoinPaprika, Hyperliquid, Polymarket, alternative.me) for informational purposes only and may be delayed. This is not investment advice.